EVH
Evolent HealthBNYSE / Health Care Equipment & Services
Last Price
At close
2026-07-21
Current thesis
The constructive read is that management reiterated full-year guidance, narrowed the GAAP loss year over year, and pointed to Q3 implementations plus a payer expansion that could materially lift revenue if approvals and launches stay on time [#8-K-2026-05-07].
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta +0.2.
What can break
Adjusted EBITDA margin fell to 4.4% from 7.6% year over year, so revenue growth is not yet converting into stronger near-term profitability.
Momentum
95
Value
50
Sentiment
40
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $4.70 · Bull $5.40 · Bear $3.30
Data freshness
Prices
As of 2026-07-21
Fundamentals
As of 2026-07-21 • Vendor: Data Vendor v1
Scores
As of 2026-07-21 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-08 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-21
Investment thesis
As of 2026-07-21
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $5.96
Why
Momentum95 · Δ7d +0.2
Value50 · Δ7d +0.3
Sentiment40 · Δ7d -1.5
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
95
26% active weight
Current posture
7d trendFlat
Δ7d
+0.2
Δ21d
+2.5
Value
50
39% active weight
Current posture
7d trendFlat
Δ7d
+0.3
Δ21d
+0.2
Sentiment
40
34% active weight
Current posture
7d trendSoftening
Δ7d
-1.5
Δ21d
-5.1
Why this grade
Composite grade B. Momentum 95.4 / Value 49.8 / Sentiment 40.1
Fundamentals (TTM)As of 2026-07-21
Fundamentals (TTM)
As of 2026-07-21
Market Cap
$658.02M
Beta
0.27
Shares Out
112.48M
P/E (TTM) · Derived
-1.2
P/S (TTM)
0.21
P/FCF (TTM) · Derived
-180.00
Rev YoY
+2.6%
EPS YoY
-62.0%
Gross Margin
+14.1%
Op Margin
-1.7%
Net Debt
$811.71M
Current Ratio
1.32
As of 2026-07-21 • Updated nightlySource: Internal modelMethodology